Conference talk highlights SPOT-Met, perhaps the world's largest in situ multiomic initiative to-date in colorectal cancer; the company also showcases platform validation data, 1,300-gene plex ...

First fully integrated spatial multiomic assay from 10x Genomics brings RNA and protein data together in situ – unlocking deeper insights into cell function and disease biology "Scientists can now ...

Collaboration with Dana-Farber Cancer Institute aims to identify biomarkers linked to treatment response for the next generation of cancer therapies and to define a clinical reporting framework to ...

Key opportunities in the Global Spatial Genomics and Transcriptomics Market include technological advancements in spatial ...

Collaboration enables researchers to begin exploring 10x single cell tools and datasets conversationally, with spatial applications to follow - making advanced analysis more accessible to the broader ...

Chang leads assay and applications development at Takara Bio, driving the commercialization of novel spatial genomics products. She has extensive experience in single-cell multiomics technologies and ...

Next-generation sequencing (NGS) was developed at the turn of the millennium, and the first complete sequence of the human genome was achieved in 2022. Recent technological developments now allow us ...

“Illumina’s…presentations and product descriptions revealed a workflow that infringed on the ‘607, ‘138, ‘505, and ‘487 patents, 10x Genomics and Prognosys Biosciences argued.” On October 21, 10x ...

The MarketWatch News Department was not involved in the creation of this content. Singular Genomics and Vanderbilt University Medical Center Establish Center of Excellence to Advance High-Throughput ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first ...